Nanomaterials for cancer immunotherapy.

Area of Science:

• Oncology
• Immunology
• Materials Science

Background:

• Cancer immunotherapy is emerging as a crucial fourth pillar of cancer treatment, complementing surgery, radiation, and chemotherapy.
• It leverages the patient's immune system for targeted cancer cell eradication, offering potential for long-lasting responses and reduced recurrence.
• Nanomaterials are increasingly vital for optimizing immunotherapy delivery and efficacy.

Purpose of the Study:

• To review the fundamental principles of cancer immunotherapy.
• To elucidate the applications and necessity of nanomaterials in enhancing cancer immunotherapy.
• To focus on the roles of nanomaterials in cancer vaccines and tumor microenvironment modulation.

Main Methods:

• Review of existing literature on cancer immunotherapy.
• Analysis of nanomaterial applications in preclinical and clinical cancer immunotherapy studies.
• Synthesis of information regarding nanomaterial-based cancer vaccines and immunomodulation strategies.

Main Results:

• Immunotherapy effectively harnesses the immune system against cancer, showing promise for durable responses.
• Nanomaterials demonstrate significant potential to improve drug delivery and therapeutic outcomes in cancer immunotherapy.
• Specific applications include enhancing cancer vaccines and modulating the tumor microenvironment for better immune cell infiltration and function.

Conclusions:

• Cancer immunotherapy represents a significant advancement in oncology.
• Nanomaterials are essential tools for overcoming delivery challenges and improving the efficacy of immunotherapies.
• Further research into nanomaterial-based strategies, especially for vaccines and tumor microenvironment modulation, is warranted for improved cancer treatment outcomes.